Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Platinum drugs and taxanes: can we overcome resistance?
Elena V. Sazonova, Gelina S. Kopeina, Evgeny N. Imyanitov, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Coumarin–benzimidazole hybrids: A review of developments in medicinal chemistry
Arya C. G, Ramesh Gondru, Yupeng Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113921-113921
Closed Access | Times Cited: 88
Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
Salima Akter, Md. Ataur Rahman, Mohammad Nazmul Hasan, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 650-650
Open Access | Times Cited: 62
Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells
Michał Antoszczak, Sebastian Müller, Tatiana Cañeque, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 26, pp. 11536-11545
Closed Access | Times Cited: 46
When cell death goes wrong: inflammatory outcomes of failed apoptosis and mitotic cell death
Florian J. Bock, Joel S. Riley
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 293-303
Open Access | Times Cited: 41
Hypoxia Enhances Glioma Resistance to Sulfasalazine-Induced Ferroptosis by Upregulating SLC7A11 via PI3K/AKT/HIF-1α Axis
Shicheng Sun, Changfa Guo, Taihong Gao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 38
Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death
Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 388-388
Open Access | Times Cited: 11
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 11
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
Rui Fu, Borui Zhao, Min Chen, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 19
Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms
Yue Shi, Joseph Adu‐Amankwaah, Qizhong Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27207-e27207
Open Access | Times Cited: 6
Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects
Shahil Alam, P. Giri
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
An overview of BAP1 biological functions and current therapeutics
Abdelrahman M. Elsayed, Muaiad Kittaneh, Colleen M. Cebulla, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189267-189267
Open Access
Protective effect of Panax ginseng extract on cisplatin-induced AKI via downregulating cell death associated genes
Reza Alipanah-Moghadam, Vahideh Aghamohammadi, Safora Seifi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Investigation of the sensitivity of human A549 cells to paclitaxel and sesquiterpene lactone alantolactone via apoptosis induction
İrem BAYAR, Yalçın Erzurumlu, Senem Akkoç, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy
Elena Giusto, Ludmila Žárská, Darren Fergal Beirne, et al.
Nanomaterials (2022) Vol. 12, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 23
Ceramides and their roles in programmed cell death
Martina Bago Pilátová, Zuzana Solárová, Roman Mezencev, et al.
Advances in Medical Sciences (2023) Vol. 68, Iss. 2, pp. 417-425
Closed Access | Times Cited: 12
Strategies for the prevention or reversal of PARP inhibitor resistance
Zahi Mitri, Shaun Goodyear, Gordon B. Mills
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 10, pp. 959-975
Open Access | Times Cited: 4
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Elisa Pardella, Erica Pranzini, Ilaria Nesi, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4026-4026
Open Access | Times Cited: 18
Investigation of Siderophore–Platinum(IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo
Chuchu Guo, Kwo-Kwang A. Wang, Elizabeth M. Nolan
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1250-1266
Closed Access | Times Cited: 3
Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer
Margareta Pernar Kovač, Vanja Tadić, Juran Kralj, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 10
Open Access | Times Cited: 9
Trinuclear ruthenium(II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment
Athi Welsh, Refilwe Matshitse, Saif F. Khan, et al.
Journal of Inorganic Biochemistry (2024) Vol. 256, pp. 112545-112545
Open Access | Times Cited: 2
Targeting Cancer Stem Cells with Radioimmunotherapy: The Case of the Ovarian Cancer Stemness-Associated Biomarker L1CAM
Tihomir Zh. Todorov, Roger Schibli, Martin Béhé, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 3, pp. 463-485
Open Access | Times Cited: 2
Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer
Sadia Sarwar, Viacheslav Morozov, Mallory A. Newcomb, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 2
Early Mechanisms of Chemoresistance in Retinoblastoma
Michelle G. Zhang, Jeffim N. Kuznetsoff, Dawn A. Owens, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4966-4966
Open Access | Times Cited: 13
Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer
Pakhi Sharma, Kartikey Patnala, Nishtha Sah, et al.
Process Biochemistry (2023) Vol. 138, pp. 33-46
Closed Access | Times Cited: 7
Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer
Sadia Sarwar, Viacheslav Morozov, Hamsa Thayele Purayil, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top